IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q1 2025 Holdings

Filed 2025-05-15 | 14 holdings | $8.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biontech SE(BNTX)COM09075V102$8.0M87,56397.9%
Exelixis Inc(EXEL)COM30161Q104$32.4K878,5330.4%
United Therapeutics Corp(UTHR)COM91307C102$30.3K98,2280.4%
Cardinal Health Inc(CAH)COM14149Y108$26.0K188,7450.3%
Supernus Pharmaceuticals Inc(SUPN)COM868459108$14.1K431,9860.2%
Jazz Pharmaceuticals PLC(JAZZ)COMG50871105$12.5K100,7030.2%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$11.7K2,116,5860.1%
GSK PLC(GSK)COM37733W204$10.5K272,0000.1%
Indivior PLC(INDV)COMG4766E116$9.2K965,3680.1%
Sanofi(SNY)COM80105N105$8.3K149,0960.1%
Avadel PharmaceuticalsCOMG29687103$7.4K950,0000.1%
Alkermes PLC(ALKS)COMG01767105$6.9K207,8220.1%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$3.5K754,3810.0%
Mural Oncology PLCCOMG63365103$8970,2630.0%